Skip to main content
Premium Trial:

Request an Annual Quote

NCI to Issue Cancer Modeling Grants

NEW YORK (GenomeWeb News) – The National Cancer Institute plans to reissue a request for applications for research into cancer modeling and control interventions such as screening, treatment, and prevention, how they are used and how effective they are.

These research efforts may include studies using genomics and family histories, biomarker studies, diagnostics, and other areas.

NCI plans to re-issue the Cancer Intervention and Surveillance Modeling Network call for applications sometime in June, and expects applications to be due in the fall of 2009.

The CISNET program will have $5.4 million set aside for the first year, and $6 million per year in years two to five.

NCI expects that the awards will be capped at around $1.3 million in the first year, but many applicants with fewer modeling groups may be expected to propose budgets considerably less than that, although increases will be allowable for years two to five.

Because of a requirement in the grant program that researchers should conduct cross-model comparisons and coverage of a range of cancer control issues, NCI expects that each award will support between two and five modeling groups working together.

These research programs could involve multi-scale and upstream modeling, incorporating genomic and family history risk profiles; evaluating diagnostic tests; optimizing biomarker development strategies; interactive policy-level decision making tools; translation of trial results into clinical guidelines and public health policy, and others.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more